Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Coherus BioSciences
Coherus BioSciences
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Loqtorzi
Toripalimab
2023-10-27
Nasopharyngeal carcinoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Toripalimab
neoplasms
,
non-small-cell lung carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
Zimberelimab
neoplasms
,
carcinoma
,
ovarian neoplasms
,
urinary bladder neoplasms
,
esophageal neoplasms
,
uterine cervical neoplasms
,
breast neoplasms
,
endometrial neoplasms
,
merkel cell carcinoma
,
non-hodgkin lymphoma
,
multiple myeloma
,
large b-cell lymphoma diffuse
,
recurrence
,
glioblastoma
,
head and neck neoplasms
,
mouth neoplasms
,
oropharyngeal neoplasms
,
pharyngeal neoplasms
,
laryngeal neoplasms
,
hypopharyngeal neoplasms
,
triple negative breast neoplasms
,
renal cell carcinoma
,
squamous cell carcinoma of head and neck
,
castration-resistant prostatic neoplasms
,
lung neoplasms
,
pancreatic neoplasms
,
melanoma
,
colorectal neoplasms
,
squamous cell carcinoma
,
cholangiocarcinoma
,
prostatic neoplasms
,
kidney neoplasms
,
rectal neoplasms
,
gastrointestinal diseases
,
adenosquamous carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
small cell carcinoma
,
pancreatic ductal carcinoma
,
bile duct neoplasms
,
biliary tract neoplasms
,
adenocarcinoma
,
non-small-cell lung carcinoma
,
stomach neoplasms
Gilvetmab
squamous cell carcinoma of head and neck
Aglatimagene besadenovec
prostatic neoplasms
ETRUMADENANT
colorectal neoplasms
,
pancreatic neoplasms
Globulin, immune
neoplasms
,
sarcoma
,
psoriasis
,
small cell lung carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use